Skip to main content

Startups Are Using AI to Predict Responses to Cancer Drugs

San Francisco Member Terri Shieh-Newton, PhD spoke to the Wall Street Journal about the use of AI in the life sciences industry, specifically on how biomedical startups are using AI to predict patient responses to cancer treatments. Terri noted that while AI allows researchers to pull diverse sets together, humans must make careful decisions about the data sets they use to train the algorithms.

Terri said, “There’s a human judgment that’s really needed. With machine learning, it’s easy to get off on the wrong foot.”


The Wall Street Journal